Achema middle east

News

Fujifilm Diosynth Biotechnologies Unveils Strategic Customer-Focused Business Structure

FUJIFILM Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses, disclosed a new strategic business unit (SBU) structure to provide tailored support to large- and small-scale biopharmaceutical customers with high quality...

Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon

Charles River Laboratories International, Inc. announced a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon. The rare disease organization will leverage Charles River’s market leading cell and gene contract development and manufacturing organization (CDMO) expertise in High Quality...

Qosina Adds OneShot Single Use Filling Needles from Overlook Industries to Its Bioprocess Components Portfolio

Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce OneShot™ single-use filling needles from Overlook Industries, a manufacturer of single-use filling needles and molded fluid path assemblies for pharma and...

Pharma Protective Packaging – Consistent Growth In The Making

Protective Packaging Market: The global protective packaging market size is expected to reach around USD 46,243.03 million by 2032 and is poised to grow at a CAGR of 4.6% from 2023 to 2032. Crisis - Resilience: Analyzing the COVID-19 effect on...

How to Find Top Talent in the Pharmaceutical Industry

Hiring the right talent can be challenging in the highly competitive pharmaceutical industry. The industry is extremely regulated, and candidates must possess specific certifications and qualifications to be hired. The right candidate for a specific vacancy in your organization...

Temperature-Controlled Packaging As The Key To Drug Safety

The global market for pharmaceutical temperature-controlled packaging solutions is anticipated to reach approximately USD 843.5 million by the year 2028, as projected by Precedence Research. This growth is driven by a surge in demand for temperature-sensitive medicines and the...

Last-Mile Solution For Temperature-Sensitive Pharmaceuticals

Pharmaceutical products undergo an extensive journey from lab to patient, traversing various modes of transportation in the supply chain. The last leg of this journey, known as the "last mile," becomes particularly complex in the cold chain. This stage...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »